Phyllis R. Yale
Known title: DirectorCIK: 0001269070
Associated companies
Transaction History
| DVA | ▲ Buy | Grant | 278 | $0 | 8/15/2026 | View on chart |
| DVA | ▼ Sell | Gift | 5,038 | $0 | 5/26/2026 | View on chart |
| DVA | ▲ Buy | Grant | 250 | $0 | 5/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 332 | $0 | 3/15/2026 | View on chart |
| DVA | ▲ Buy | Grant | 411 | $0 | 11/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 369 | $0 | 8/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 348 | $0 | 5/15/2025 | View on chart |
| DVA | ▲ Buy | Grant | 349 | $0 | 3/15/2025 | View on chart |
| DVA | ▼ Sell | Gift | 3,500 | $0 | 12/2/2024 | View on chart |
| DVA | ▲ Buy | Grant | 312 | $0 | 11/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 333 | $0 | 8/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 363 | $0 | 5/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 366 | $0 | 3/15/2024 | View on chart |
| DVA | ▲ Buy | Grant | 529 | $0 | 11/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 8/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 516 | $0 | 5/15/2023 | View on chart |
| DVA | ▲ Buy | Option Exercise | 7,165 | $475K | 5/12/2023 | View on chart |
| DVA | ▼ Sell | Open Market | 2,196 | $209K | 5/12/2023 | View on chart |
| DVA | ▼ Sell | Other | 4,969 | $475K | 5/12/2023 | View on chart |
| DVA | ▲ Buy | Grant | 658 | $0 | 3/15/2023 | View on chart |
| DVA | ▲ Buy | Grant | 677 | $0 | 11/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 514 | $0 | 8/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 475 | $0 | 5/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 429 | $0 | 3/15/2022 | View on chart |
| DVA | ▲ Buy | Grant | 446 | $0 | 11/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer
Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.
DaVita (DVA) Discussed as Potentially Undervalued Cash Producer. Recent articles highlight DaVita as a cash-producing stock that may be undervalued relative to its earnings power. The company has outperformed the broader market recently, with one analysis noting a 58% gain. While the stock is trading near its 52-week low, analysts maintain a higher average price target, suggesting a gap between current price and long-term expectations.